Merck & Co., Inc. is 83.3x more valuable than Organon & Co. by market capitalization ($294.03 B vs $3.53 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | OGN | MRK |
|---|---|---|
| Market cap | $3.53 B | $294.03 B |
| US-listed rank | #1699 | #45 |
| Revenue (latest FY) | $6.22B | $65.01B |
| Net income (latest FY) | $187.00M | $18.25B |
| Net margin | 3.0% | 28.1% |
| P/E (trailing FY) | 18.9 | 16.1 |
| SEC filings | 433 | 996 |
Merck & Co., Inc. is 83.3x more valuable than Organon & Co. by market capitalization ($294.03 B vs $3.53 B).
In their latest fiscal years, Organon & Co. reported $6.22B in revenue while Merck & Co., Inc. reported $65.01B.
Full pages: Organon & Co. and Merck & Co., Inc., or browse the full rankings.